Contributo in volume, 2023, ENG, 10.1021/bk-2023-1436.ch011
Ashkan Bigham and Maria Grazia Raucci
Institute of Polymers, Composites and Biomaterials (IPCB-CNR)
Single-responsive biomaterials have been of great importance for three decades in biomedical applications and cancer therapy in particular. However, the need for improvement in their efficiency and therapeutic results can still be felt. Evolved from these nanocarriers, multi-responsive ones have gained immense attention recently because of their multifunctionality--targetability, hyperthermia, ROS generation, smart and controlled drug release, and imaging. Due to complex structure of cancerous tumors, these nanomaterials are more applied in this field with more promising outcomes under a term called combined therapy. Multi-responsive nanocarriers are divided into three main groups: endogenous or internal, exogenous or external, and the integration of both. This chapter focuses on nanomaterials responsive to more than one stimulus in cancer therapy. The internal (pH, enzyme, GSH, etc.), external (light, ultrasound, magnetism, etc.), and combination of both are covered separately.
cancer therapy, cells, drug release, tumors, nanoparticles
Bigham Ashkan, Raucci Maria Grazia
ID: 481429
Year: 2023
Type: Contributo in volume
Creation: 2023-05-14 16:52:59.000
Last update: 2023-05-23 18:44:53.000
CNR authors
CNR institutes
External links
OAI-PMH: Dublin Core
OAI-PMH: Mods
OAI-PMH: RDF
DOI: 10.1021/bk-2023-1436.ch011
URL: https://pubs.acs.org/doi/pdf/10.1021/bk-2023-1436.ch011
External IDs
CNR OAI-PMH: oai:it.cnr:prodotti:481429
DOI: 10.1021/bk-2023-1436.ch011